Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: Role of Tirofiban and the Paclitaxel Eluting Stent in Postfibrinolysis Angioplasty [Phase 4]
A Phase 4 trial update evaluating the use of tirofiban and a paclitaxel-eluting stent during postfibrinolysis angioplasty in patients with m…
-
CLINICAL_TRIALS research · 2009-09-23Clinical Trial Update: Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction [NA]
A clinical trial update describing a study on drug-eluting strategies and distal protection during percutaneous coronary intervention in ST-…
-
CLINICAL_TRIALS research · 2009-09-17Clinical Trial Update: Myocardial Infarction With ST-Elevation [Phase 3]
A Phase 3 clinical trial update for myocardial infarction with ST-elevation is reported, but the status is listed as UNKNOWN. No drug detail…
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: The Study to Assess AMI Treated With Balloon Angioplasty. [Phase 3]
Phase 3 trial evaluating balloon angioplasty for acute myocardial infarction has completed.
-
FDA approval · 2009-09-02FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Atenolol from Aurobindo Pharma Limited, confirming approval of a generic Atenolol product under …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-08-31FDA Approved: HEPARIN SODIUM — Original Application (Hospira, Inc.)
FDA approved an original ANDA for heparin sodium, enabling its generic commercialization by Hospira, Inc.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Risk Markers in the Acute Coronary Syndromes
Clinical trial update reporting on risk markers in acute coronary syndromes; study completed with results posted in 2009.
-
CLINICAL_TRIALS research · 2009-08-11Clinical Trial Update: The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort Study [NA]
An update on PREVENT, a post-stroke preventive randomized trial nested in a cohort, with current status not disclosed.
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes [Phase 4]
Phase 4 trial update from Eli Lilly examining hyperglycemia and cardiovascular outcomes in patients with type 2 diabetes and a history of ac…
-
CLINICAL_TRIALS research · 2009-07-24Clinical Trial Update: Effectiveness of Intracoronary Injection of Eptifibatide in Primary Coronary Intervention in STEMI Patients [Phase 2]
Phase 2 clinical trial evaluating intracoronary injection of eptifibatide during primary percutaneous coronary intervention in patients with…
-
FDA approval · 2009-07-23FDA Approved: HEPARIN SODIUM AND DEXTROSE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Heparin Sodium and Dextrose (Heparin Sodium) from Hospira, Inc. The approval updates the product…
-
CLINICAL_TRIALS trial_result · 2009-07-15Clinical Trial Update: Efficacy of High Dose atorvaSTATIN Loading Before Primary Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction (STATIN STEMI) [Phase 4]
Phase 4 clinical trial update assessing high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-elevation myo…
-
CLINICAL_TRIALS trial_result · 2009-07-15Clinical Trial Update: Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With Magnetic Resonance Imaging (MRI)
This completed clinical trial evaluated rapid diagnosis of myocardial damage and coronary stenosis using magnetic resonance imaging (MRI).
-
CLINICAL_TRIALS research · 2009-06-23Clinical Trial Update: Type 2 Diabetes and Acute Myocardial Infarction
Clinical trial update examining the interplay between Type 2 diabetes mellitus and acute myocardial infarction, with impaired glucose tolera…
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction [Phase 4]
A Phase 4 trial from Istanbul University evaluated whether adjunctive intracoronary streptokinase affects late-term left ventricular infarct…
-
CLINICAL_TRIALS trial_result · 2009-06-19Clinical Trial Update: Hair Cortisol and the Risk of Acute Myocardial Infarction
This entry notes a completed clinical trial examining whether hair cortisol levels are associated with the risk of acute myocardial infarcti…
-
CLINICAL_TRIALS trial_result · 2009-06-17Clinical Trial Update: Impact at One Year of a Secondary Prevention Educational Program on Cardiovascular Risk Factors
This updates the one-year results of a secondary prevention educational program for patients with prior myocardial infarction or acute coron…
-
FDA approval · 2009-05-29FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC, enabling continued access to lisinopril…
-
CLINICAL_TRIALS trial_result · 2009-05-28Clinical Trial Update: SPECTACL: SPECTroscopic Assessment of Coronary Lipid [Phase 2, Phase 3]
Phase 2/3 trial update for SPECTACL assessing coronary lipid via spectroscopy in angina conditions; trial completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2009-05-20Clinical Trial Update: Acute Balloon Angioplasty vs. Traditional Early Invasive Treatment of Non-ST-Elevation Myocardial Infarction [NA]
The trial comparing acute balloon angioplasty to traditional early invasive treatment for non-ST-elevation myocardial infarction was termina…
-
CLINICAL_TRIALS trial_result · 2009-05-15Clinical Trial Update: A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse) [Phase 3]
A Phase 3 trial update reporting results for the Finesse study evaluating Abciximab and Reteplase administered before catheterization in pat…
-
FDA approval · 2009-04-29FDA Approved: TECHNETIUM TC 99M SESTAMIBI — Original Application (Jubilant Draximage (USA) Inc.)
FDA approved Jubilant Draximage (USA) Inc.'s original ANDA for Technetium Tc-99m Sestamibi, a radiopharmaceutical used in myocardial perfusi…
-
EMA withdrawal · 2009-04-23EMA Application withdrawn: Clopidogrel Teva Pharma (clopidogrel) — Teva Pharma B.V.
The EMA application for Clopidogrel Teva Pharma (clopidogrel) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25) [Phase 3]
ExTRACT-TIMI25 is a Phase 3 trial evaluating enoxaparin with thrombolysis for acute myocardial infarction in STEMI. The study status is comp…
-
CLINICAL_TRIALS research · 2009-04-17Clinical Trial Update: Norwegian Study on District Treatment of ST-Elevation Myocardial Infarction [NA]
This document provides an update on a Norwegian clinical trial evaluating district-level treatment approaches for ST-elevation myocardial in…